BUSINESS● LOWAug 10 · Aug 10, 2026, 12:54 PM
Jazz Pharmaceuticals to acquire Actio Biosciences for $1.32B
Seeking Alpha Tech
Jazz Pharmaceuticals is set to acquire Actio Biosciences in a transaction valued at $1.32 billion. This represents a significant business acquisition in the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS13m agoA wrong model is not solved with AILa Silla VacíaBUSINESS19m agoSingapore, Hong Kong take different paths in race for stablecoin dominance. Who will win?South China Morning Post